Literature DB >> 2889715

Loss of genes on chromosome 22 in medullary thyroid carcinoma and pheochromocytoma.

S Takai1, H Tateishi, I Nishisho, T Miki, K Motomura, A Miyauchi, M Kato, T Ikeuchi, K Yamamoto, M Okazaki.   

Abstract

Using polymorphic DNA markers, we compared the constitutional and tumor genotypes of patients with multiple endocrine neoplasia type 2A (MEN2 A). We found loss of constitutional heterozygosity at the D22S9 locus in one out of 9 medullary thyroid carcinomas (MTCs). No loss of heterozygosity was detected at 12 other loci in any of the MTCs tested. Loss of heterozygosity at D22S9 and/or D22S1 was also demonstrated in 2 out of 5 pheochromocytomas tested. These results suggest that loss or mutation of a gene on chromosome 22 may play an important role in tumorigenesis in MEN2A.

Entities:  

Mesh:

Year:  1987        PMID: 2889715

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  9 in total

1.  Comparative genomic hybridization reveals frequent losses of chromosomes 1p and 3q in pheochromocytomas and abdominal paragangliomas, suggesting a common genetic etiology.

Authors:  E Edström; E Mahlamäki; B Nord; M Kjellman; R Karhu; A Höög; N Goncharov; B T Teh; M Bäckdahl; C Larsson
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

2.  Loss of heterozygosity suggests multiple genetic alterations in pheochromocytomas and medullary thyroid carcinomas.

Authors:  S Khosla; V M Patel; I D Hay; D J Schaid; C S Grant; J A van Heerden; S N Thibodeau
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

Review 3.  Biology of tumors of the peripheral nervous system.

Authors:  G M Brodeur; J F Moley
Journal:  Cancer Metastasis Rev       Date:  1991-12       Impact factor: 9.264

Review 4.  Genetics of cancer predisposition and progression.

Authors:  K Schwechheimer; W K Cavenee
Journal:  Clin Investig       Date:  1993-06

5.  Deficiency of Phenylethanolamine N-Methyltransferase in Norepinephrine-Producing Pheochromocytoma.

Authors:  Noriko Kimura; Akira Togo; Takako Sugimoto; Koji Nata; Hiroshi Okamoto; Ikuko Nagatsu; Hiroshi Nagura
Journal:  Endocr Pathol       Date:  1996       Impact factor: 3.943

Review 6.  Molecular mechanisms of cancer.

Authors:  H P Koeffler; F McCormick; C Denny
Journal:  West J Med       Date:  1991-11

7.  ATF4 loss of heterozygosity is associated with poor overall survival in medullary thyroid carcinoma.

Authors:  Michelle D Williams; Junsheng Ma; Elizabeth G Grubbs; Robert F Gagel; Rozita Bagheri-Yarmand
Journal:  Am J Cancer Res       Date:  2021-06-15       Impact factor: 6.166

8.  Deletion mapping of chromosome 1p and 22q in pheochromocytoma.

Authors:  E Shin; S Fujita; K Takami; H Kurahashi; Y Kurita; T Kobayashi; T Mori; I Nishisho; S Takai
Journal:  Jpn J Cancer Res       Date:  1993-04

9.  Novel point mutations and allele loss at the RET locus in sporadic medullary thyroid carcinomas.

Authors:  S Uchino; S Noguchi; M Adachi; M Sato; H Yamashita; S Watanabe; T Murakami; M Toda; N Murakami; H Yamashita
Journal:  Jpn J Cancer Res       Date:  1998-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.